Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 466, Issue 1, 2000, Pages 17-26

  Guyonnet, Denis ^a   Belloir, Christine ^a   Suschetet, Marc ^a   Siess, Marie Hélène ^a   Le Bon, Anne Marie ^a  

^a CEMAGREF   (France)

Author keywords

Benzo a pyrene; Cyclophosphamide; Modulation of mutagenicity; Nitrosamines; Organosulfur compounds; PhIP

Indexed keywords

BENZO[A]PYRENE; CYCLOPHOSPHAMIDE; NITROSAMINE; ORGANOSULFUR DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GARLIC; GENOTOXICITY; LIVER METABOLISM; MALE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALLIUM; ALLYL COMPOUNDS; ANIMALS; BENZO(A)PYRENE; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DIMETHYLNITROSAMINE; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; LIVER EXTRACTS; MALE; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; NITROSAMINES; OXIDOREDUCTASES; PROPANE; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS; SULFIDES;

ALLIUM; ALLIUM SATIVUM; ANIMALIA; RATTUS NORVEGICUS;

EID: 0034599106     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00234-X     Document Type: Article

References (44)

1. [1] E. Dorant, P.A. Van den Brandt, R.A. Goldbohm, F. Sturmans, Consumption of onions and a reduced risk of stomach carcinoma, Gastroenterology 110 (1996) 12-20.
2. [2] E. Dorant, P.A. Van den Brandt, R.A. Goldbohm, R.J. Hermus, F. Sturmans, Garlic and its significance for the prevention of cancer in humans: a critical view, Br. J. Cancer 67 (1993) 424-429.
3. [3] K.A. Steinmetz, L.H. Kushi, R.M. Bostick, A.R. Folsom, J.D. Potter, Vegetables, fruit, and colon cancer in the Iowa Women's Health Study, Am. J. Epidemiol. 139 (1994) 1-15.
4. [4] E. Buiatti, D. Palli, A. Decarli, D. Amadori, C. Avellini, S. Bianchi, R. Biserni, F. Cipriani, P. Cocco, A. Giacosa, E. Marubini, R. Puntoni, C. Vindigni, J. Fraumeni, W. Blot, A case - control study of gastric cancer and diet in Italy, Int. J. Cancer 44 (1989) 611-616.
5. [5] F. Levi, C. Pasche, C. La Vecchia, F. Lucchini, S. Franceschi, Food groups and colorectal cancer risk, Br. J. Cancer 79 (1999) 1283-1287.
6. [6] V.L. Sparnins, G. Barany, L.W. Wattenberg, Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse, Carcinogenesis 9 (1988) 131-134.
7. [7] D. Haber-Mignard, M. Suschetet, R. Bergès, P. Astorg, M.H. Siess, Inhibition of aflatoxin B1-and N-nitrosodiethylamine-induced liver preneoplastic foci in rats fed naturally occurring allyl sulfides, Nutr. Cancer 25 (1996) 61-70.
8. [8] M.J. Wargovich, Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer, Carcinogenesis 8 (1987) 487-489.
9. [9] J.Y. Hong, Z.Y. Wang, T.J. Smith, S. Zhou, S. Shi, J. Pan, C.S. Yang, Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1 -(3 -pyridyl)-1 -butanone (NNK) in A/J mouse lung, Carcinogenesis 13 (1992) 901-904.
10. [10] J.F. Brady, D.C. Li, H. Ishizaki, C.S. Yang, Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities, Cancer Res. 48 (1988) 5937-5940.
11. [11] M.K. Kwak, S.G. Kim, J.Y. Kwak, R.F. Novak, N.D. Kim, Inhibition of cytochrome P4502E1 expression by organosulfur compounds allyl sulfide, allyl mercaptan and allyl methylsulfide in rats, Biochem. Pharmacol. 47 (1994) 531-539.
12. [12] D. Guyonnet, M.H. Siess, A.M. Le Bon, M. Suschetet, Modulation of phase II enzymes by organosulfur compounds from Allium vegetables in rat tissues, Toxicol. Appl. Pharmacol. 154 (1999) 50-58.
13. [13] B.S. Reddy, C.V. Rao, A. Rivenson, G. Kelloff, Chemoprevention of colon carcinogenesis by organosulfur compounds, Cancer Res. 53 (1993) 3493-3498.
14. [14] D. Haber, M.H. Siess, M.C. Canivenc-Lavier, A.M. Le Bon, M. Suschetet, Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes, J. Toxicol. Environ. Health 44 (1995) 423-434.
15. [15] S.V. Singh, S.S. Pan, S.K. Srivastava, H. Xia, X. Hu, H.A. Zaren, J.L. Orchard, Differential induction of NAD(P)H: quinone oxidoreductase by anti-carcinogenic organosulfides from garlic, Biochem. Biophys. Res. Commun. 244 (1998) 917-920.
16. [16] M.H. Siess, A.M. Le Bon, M.C. Canivenc-Lavier, M. Suschetet, Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides, Cancer Lett. 120 (1997) 195-201.
17. [17] J. Pan, J.Y. Hong, B.L. Ma, S.M. Ning, S.R. Paranawithana, C.S. Yang, Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic, Arch. Biochem. Biophys. 302 (1993) 337-342.
18. [18] R.W. Teel, Effect of phytochemicals on the mutagenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium strain TA1535, Phytother. Res. 7 (1993) 248-251.
19. [19] P.P. Tadi, R.W. Teel, B.H. Lau, Organosulfur compounds of garlic modulate mutagenesis, metabolism, and DNA binding of aflatoxin B1, Nutr. Cancer 15 (1991) 87-95.
20. [20] Y.J. Surh, R.C. Lee, K.K. Park, S.T. Mayne, A. Liem, J.A. Miller, Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine, Carcinogenesis 16 (1995) 2467-2471.
21. [21] M.E. Dion, M. Agler, J.A. Milner, S-allyl cysteine inhibits nitrosomorpholine formation and bioactivation, Nutr. Cancer 28 (1997) 1-6.
22. [22] A. Bu-Abbas, M.N. Clifford, R. Walker, C. Ioannides, Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea, Carcinogenesis 15 (1994) 2575-2579.
23. [23] H. Wallin, A. Mikalsen, F.P. Guengerich, M. Ingelman-Sundberg, K.E. Solberg, O.J. Rossland, J. Alexander, Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes, Carcinogenesis 11 (1990) 489-492.
24. [24] H.V. Gelboin, Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxidases and related enzymes, Physiol. Rev. 60 (1980) 1107-1166.
25. [25] A.D. Ayrton, J.N. Smith, C. Ioannides, Bioactivation of N-nitrosopiperidine to mutagens: role of hepatic cytochrome P450 proteins and contribution of cytosolic fraction, Carcinogenesis 8 (1987) 1691-1695.
26. [26] C.S. Yang, J.S. Yoo, H. Ishizaki, J.Y. Hong, Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation, Drug Metab. Rev. 22 (1990) 147-159.
27. [27] L. Clarke, D.J. Waxman, Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation, Cancer Res. 49 (1989) 2344-2350.
28. [28] L.J. Yu, P. Drewes, K. Gustafsson, E.G. Brain, J.E. Hecht, D.J. Waxman, In vivo modulation of alternative pathways of P450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity, J. Pharmacol. Exp. Ther. 288 (1999) 928-937.
29. [29] D. Haber, M.H. Siess, I. de Waziers, P. Beaune, M. Suschetet, Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides, Xenobiotica 24 (1994) 169-182.
30. [30] D.M. Maron, B.N. Ames, Revised methods for the Salmonella mutagenicity test, Mutat. Res. 113 (1983) 173-215.
31. [31] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
32. [32] W. Tassaneeyakul, M.E. Veronese, D.J. Birkett, F.J. Gonzalez, J.O. Miners, Validation of 4-nitrophenol as an in vivo substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques, Biochem. Pharmacol. 46 (1993) 1975-1981.
33. [33] V.A. Gudi, S.V. Singh, Effect of diallyl sulfide, a naturally occurring anti-carcinogen, on glutathione-dependent detoxification enzymes of female CD-1 mouse tissues, Biochem. Pharmacol. 42 (1991) 1261-1265.
34. [34] J.F. Brady, M.H. Wang, J.Y. Hong, F. Xiao, Y. Li, J.S. Yoo, S.M. Ning, M.J. Lee, J.M. Fukuto, J.M. Gapac, C.S. Yang, Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide, Toxicol. Appl. Pharmacol. 108 (1991) 342-354.
35. [35] A.H. Conney, R.L. Chang, D.M. Jerina, S.J. Wei, Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite, Drug Metab. Rev. 26 (1994) 125-163.
36. [36] H. Greim, W. Goggelmann, K.H. Summer, T. Wolff, Mutagenicity testing with Salmonella microsome test, Arch. Toxicol. 46 (1980) 31-40.
37. [37] P.J. O'Brien, Molecular mechanisms of quinone cytotoxicity, Chem. Biol. Interact. 80 (1991) 1-41.
38. [38] P. Joseph, A.K. Jaiswal, NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo[a]pyrene quinones, Br. J. Cancer 77 (1998) 709-719.
39. [39] P. Joseph, A.K. Jaiswal, NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone - DNA adducts generated by cytochrome P4501A1 and P450 reductase, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8413-8417.
40. [40] A.M. Le Bon, C. Roy, C. Dupont, M. Suschetet, In vivo antigenotoxic effects of dietary allyl sulfides in the rat, Cancer Lett. 114 (1997) 131-134.
41. [41] L.W. Wattenberg, V.L. Sparnins, G. Barany, Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes, Cancer Res. 49 (1989) 2689-2692.
42. [42] H.S. Marks, J.L. Anderson, G.S. Stoewsand, Inhibition of benzo[a]pyrene-induced bone marrow micronuclei formation by diallyl thioethers in mice, J. Toxicol. Environ. Health 37 (1992) 1-9.
43. [43] N. Suzui, S. Sugie, K.M. Rahman, M. Ohnishi, N. Yoshimi, K. Wakabayashi, H. Mori, Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats, Jpn. J. Cancer Res. 88 (1997) 705-711.
44. [44] M.T. Goldberg, P.D. Josephy, Studies on the mechanism of action of diallyl sulfide, an inhibitor of the genotoxic effects of cyclophosphamide, Can. J. Physiol. Pharmacol. 65 (1987) 467-471.